PRTA.NASDAQProthena CORP Public LTD CO

Form 4: William Scully Buys Prothena Shares

Sentiment:

Insider Transaction Filing

📋All filings for Prothena CORP Public LTD CO
🔒Login to Follow

Director William P. Scully of Prothena Corp Public Ltd Co acquired 50,000 ordinary shares in a transaction on June 2, 2026.

Summary

  • William P. Scully, a Director at Prothena Corp Public Ltd Co, acquired 50,000 ordinary shares on June 2, 2026.
  • The purchase was made at a weighted average price of $9.426 per share, with individual transactions ranging from $9.2323 to $9.4892.
  • Following this transaction, Scully beneficially owns 886,000 ordinary shares directly.
  • Additionally, he has indirect beneficial ownership of 80,000 shares through Manatee Equity Fund LLC and 52,000 shares through his spouse.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a positive signal due to the insider purchase by a director, indicating confidence in the company's value.

Positives

  • Director William P. Scully demonstrated confidence in the company by acquiring a significant number of ordinary shares.
  • The acquisition of 50,000 shares indicates a personal investment in the company's future performance.

Future Outlook

This filing does not contain forward-looking statements or guidance.

Industry Context

StockSavvy.ai notes that insider buying, such as this acquisition by Director Scully, can often be interpreted as a positive signal by the market, suggesting management's belief in the company's intrinsic value and future prospects.

Stakeholder Impact

  • Shareholders may view this acquisition positively, interpreting it as a sign of management's confidence in the company's future performance.
  • Employees may also see this as a positive indicator of the company's stability and growth potential.

Key Dates

DateDescription
06/02/2026Transaction date for the acquisition of 50,000 ordinary shares by William P. Scully.
06/03/2026Date of signature for the Form 4 filing.

Recommendation

hold

The acquisition of shares by a director is a positive signal, but it is a single transaction and does not provide sufficient information for a strong buy or sell recommendation. It warrants a 'hold' to monitor further developments and company performance.

Keywords

Prothena Corp, PRTA, Form 4, Insider Trading, Share Acquisition, Director Transaction, Beneficial Ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.